Literature DB >> 8889329

Treatment of cutaneous leishmaniasis (Old World).

Y Dowlati1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8889329     DOI: 10.1016/0738-081x(96)00047-8

Source DB:  PubMed          Journal:  Clin Dermatol        ISSN: 0738-081X            Impact factor:   3.541


× No keyword cloud information.
  8 in total

Review 1.  Parasitic skin infections in the elderly: recognition and drug treatment.

Authors:  H H Tan; C L Goh
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

2.  Comparison of intralesional two percent zinc sulfate and glucantime injection in treatment of acute cutaneous leishmaniasis.

Authors:  Masoud Maleki; Gholamreza Karimi; Mohsen Tafaghodi; Somayyeh Raftari; Yalda Nahidi
Journal:  Indian J Dermatol       Date:  2012-03       Impact factor: 1.494

3.  Efficacy of thermotherapy to treat cutaneous leishmaniasis: a meta-analysis of controlled clinical trials.

Authors:  Jaiberth Antonio Cardona-Arias; Iván Darío Vélez; Liliana López-Carvajal
Journal:  PLoS One       Date:  2015-05-26       Impact factor: 3.240

4.  Cutaneous leishmaniasis in suspected patients referred to the center for research and training in skin diseases and leprosy, tehran, iran from 2008 to 2011.

Authors:  Akram Mir Amin Mohammadi; Ali Khamesipour; Alireza Khatami; Amir Javadi; Mansour Nassiri-Kashani; Alireza Firooz; Yahya Dowlati; Massoud Behnia; Seyyed Ebrahim Eskandari
Journal:  Iran J Parasitol       Date:  2013-07       Impact factor: 1.012

5.  Combination of topical liposomal amphotericin B and Glucantime in comparison with glucantime alone for the treatment of anthroponotic cutaneous leishmaniasis (ACL) caused by Leishmania tropica: study protocol for a randomized, controlled trial.

Authors:  Seyed Ebrahim Eskandari; Ali Khamesipour; Mahmoud Reza Jaafari; Amir Javadi; Akram Miramin Mohammadi; Hossein Keshavarz Valian; Mansour Nassiri-Kashani; Vahid Mashayekhi Goyonlo; Alireza Firooz
Journal:  Iran J Microbiol       Date:  2021-10

6.  Interleukin-10 and Transforming Growth Factor-β in Early and Late Lesions of Patients with Leishmania major induced Cutaneous Leishmaniasis.

Authors:  Sh Hejazi; Sg Hoseini; Sh Javanmard; Sh Zarkesh; A Khamesipour
Journal:  Iran J Parasitol       Date:  2012       Impact factor: 1.012

7.  Interleukin-10 and Transforming Growth Factor-β in Early and Late Lesions of Patients with Leishmania major Induced Cutaneous Leishmaniasis.

Authors:  Sh Hejazi; Sg Hoseini; Sh Javanmard; Sh Zarkesh; A Khamesipour
Journal:  Iran J Parasitol       Date:  2012       Impact factor: 1.012

8.  Comparison of immune regulatory factors in acute and chronic lesions of cutaneous leishmaniasis due to Leishmania major.

Authors:  Shervin Ghaffari Hoseini; Shaghayegh Haghjooy Javanmard; Seyed Hossein Hejazi; Laleh Rafiei; Sayyed Hamid Zarkesh; Khadije Karbalaii; Ali Khamesipour
Journal:  J Res Med Sci       Date:  2014-03       Impact factor: 1.852

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.